[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Claus Bogh Juhl\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":77},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100634641","the-role-of-autoantibodies-against-g-protein-coupled-receptors-in-obesity-100634641",false,"NCT07542327","The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity","Inclusion Criteria:\n\n* Inhabitant in the Region of Southern Denmark\n* BMI above 30kg\u002Fm2\n* age between 18 and 60 years.\n\nExclusion Criteria:\n\n* individuals previously treated with GLP-1RA medication for any indication\n* Individuals who have previously undergone bariatric surgery\n* Individuals with type 1 diabetes","ALL","18 Years","60 Years",{"count":19,"type":20},160,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to explore if GPCR-autoantibodies:\n\n1. are pressent in people living with obesity, and are associated with degree of obesity\n2. if it is associated with obesity related diseases",[24,25,26,27],"Obesity","Obesity & Overweight","Obesity Type 2 Diabetes Mellitus","Obesity and Obesity-related Medical Conditions",[24,29,30],"obesity-related medical conditions","GPCR- autoantibodies","NOT_YET_RECRUITING","2026-04-21",{"date":34,"type":35},"2026-04-24","ACTUAL",{"date":37,"type":20},"2026-09-01",{"date":39,"type":20},"2027-09-01",{"name":41,"class":42},"Claus Bogh Juhl","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":53,"targetDuration":55,"studyType":21,"phases":4,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":43},"100452793","south-danish-obesity-initiative-screening-for-unrecognized-obesity-related-disease-100452793","NCT05176132","South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease","South Danish Obesity Initiative (SDOI)","SDOI","Inclusion Criteria:\n\n* BMI \\>30 (Obese cohort), BMI 20-25 (control group I), BMI 25-30 (control group II)\n* Age 18-60 years\n\nExclusion Criteria:\n\n* None",true,{"count":54,"type":20},2700,"5 Years","People with BMI \\>30 kg\u002Fm2 will be included in at population-based cohort. Additionally, one control group with BMI 18.5-25 kg\u002Fm2 and one control group with BMI 25-30 kg\u002Fm2 will be included. All participants with age 18 and 60 years.\n\nTo evaluate health status participants will be screened by for undetected obesity-related diseases (hypertension, diabetes, dyslipidemia, sleep apnea, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, EKG-abnormalities, polycystic ovary syndrome (PCOS), and joint pain and for quality of life at baseline, 1 year, and 5 years. Additionally, anthropometric measurements are collected and a biobank is established for future research studies.\n\nPeople with obesity related disease will be offered participation in a 12 month personalized lifestyle intervention program aimed at improvement of health and self-perception.\n\nThe collected data will be used to detect the prevalence for obesity-related disease to identify predictors for future obesity related disease and to evaluate the effect of a lifestyle intervention on health and quality of life.",[24],[24,59,60,61,62,63,64,65,66,67],"Lifestyle intervention","BMI","Cohort","sleep apnea","diabetes","PCOS","NAFLD","Hypertension","Hyperlipidemia","RECRUITING","2023-10-18",{"date":71,"type":35},"2023-10-19",{"date":73,"type":35},"2020-09-01",{"date":75,"type":20},"2030-09-01",{"name":41,"class":42},""]